# Study on the Efficacy and Safety of Gelaspan

> **NCT02808325** · PHASE3 · COMPLETED · sponsor: **B. Braun Medical LLC** · enrollment: 72 (actual)

## Conditions studied

- Hypovolemia

## Interventions

- **DRUG:** Gelaspan 4%
- **DRUG:** Gelofusine 4%

## Key facts

- **NCT ID:** NCT02808325
- **Lead sponsor:** B. Braun Medical LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2017-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02808325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02808325, "Study on the Efficacy and Safety of Gelaspan". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02808325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*